<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1242">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 01, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02323256</url>
  </required_header>
  <id_info>
    <org_study_id>2014.857</org_study_id>
    <nct_id>NCT02323256</nct_id>
  </id_info>
  <brief_title>Neurophysiological Measures of Auditory Perception and Rehabilitation in Cochlear Implanted Patients</brief_title>
  <acronym>NEUROSYLLABIC</acronym>
  <official_title>Neurophysiological Measures During Sound and Speech Perception in Cochlear Implanted Patients and Development of New Speech Rehabilitation Tools</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at investigating new automatic fitting techniques for cochlear implant
      patients based on objective measures. For this reason, the evolution of these
      neurophysiological measures, expressing the encoding of pure tones and speech, will be
      characterized in cochlear implanted patients as a function of post-implantation time and
      will be compared to those of normal hearing subjects. Moreover, the effect of auditory
      training with new tools based on serious games will be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Amplitude of auditory steady state responses ASSR</measure>
    <time_frame>one year at least after CI activation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Spectro-temporal analysis of speech-ABR</measure>
    <time_frame>one year at least after CI activation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Acoustic Change Complex ACC</measure>
    <time_frame>one year at least after CI activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Amplitudes and latencies of ACC</description>
  </primary_outcome>
  <primary_outcome>
    <measure>amplitudes and latencies of P1/N1/P2 complex and Mismatch Negativity MMN</measure>
    <time_frame>one year at least after CI activation</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution of amplitude of auditory steady state responses ASSR</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months and 12 months after CI activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evolution of ASSR amplitudes as a function of time during the first year of CI activation in newly implanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evolution of spectro-temporal analysis of speech-ABR</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months and 12 months after CI activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evolution of spectro-temporal analysis of speech-ABR as a function of time during the first year of CI activation in newly implanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acoustic Change Complex ACC</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months and 12 months after CI activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evolution of amplitudes and latencies of ACC as a function of time during the first year of CI activation in newly implanted patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>amplitudes and latencies of P1/N1/P2 complex and Mismatch Negativity MMN</measure>
    <time_frame>1 month, 3 months, 6 months, 9 months and 12 months after CI activation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evolution of amplitudes and latencies of P1N1P2 and MMN as a function of time during the first year of CI activation in newly implanted patients</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">432</enrollment>
  <condition>Deafness</condition>
  <arm_group>
    <arm_group_label>newly cochlear implanted adult patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>longitudinal group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>newly cochlear implanted children</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>longitudinal group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cochlear implanted adult patients (CI&gt;1 year)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>transversal group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal hearing adult subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>transversal group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Auditory steady-state response ASSR</intervention_name>
    <description>comparison of ASSR amplitudes in response to amplitude-modulated sounds delivered at different intensities</description>
    <arm_group_label>newly cochlear implanted adult patients</arm_group_label>
    <arm_group_label>newly cochlear implanted children</arm_group_label>
    <arm_group_label>cochlear implanted adult patients (CI&gt;1 year)</arm_group_label>
    <arm_group_label>normal hearing adult subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Speech-ABR</intervention_name>
    <arm_group_label>newly cochlear implanted adult patients</arm_group_label>
    <arm_group_label>newly cochlear implanted children</arm_group_label>
    <arm_group_label>cochlear implanted adult patients (CI&gt;1 year)</arm_group_label>
    <arm_group_label>normal hearing adult subjects</arm_group_label>
    <other_name>comparison of spectro-temporal analysis of speech-ABR generated in response to speech syllables</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acoustic Change Complex ACC</intervention_name>
    <description>comparison of ACC complex in response to changes within speech stimulation</description>
    <arm_group_label>newly cochlear implanted adult patients</arm_group_label>
    <arm_group_label>newly cochlear implanted children</arm_group_label>
    <arm_group_label>cochlear implanted adult patients (CI&gt;1 year)</arm_group_label>
    <arm_group_label>normal hearing adult subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>P1-N1-P2 complex and Mismatch Negativity MMN</intervention_name>
    <description>comparison of amplitudes and latencies of P1-N1-P2 complex and MMN generated in response to the detection of changes in a series of auditory stimulation</description>
    <arm_group_label>newly cochlear implanted adult patients</arm_group_label>
    <arm_group_label>newly cochlear implanted children</arm_group_label>
    <arm_group_label>cochlear implanted adult patients (CI&gt;1 year)</arm_group_label>
    <arm_group_label>normal hearing adult subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  native French speaker

          -  no medical treatment for behavior or neurological disorders

          -  normal or corrected vision

          -  right-handed

          -  normal ORL examination

          -  valid affiliation to social security

          -  absence of participation to another study

        For the cochlear implanted patients:

          -  aged from 1 to 70

          -  bilateral severe to profound deafness

          -  cochlear implant

          -  congenital deafness, pre or post lingual

        For the normal-hearing subjects:

          -  Aged from 18 to 70

          -  Normal tonal audiometry

        Exclusion Criteria:

          -  No signed consent

          -  Treatment for depression, epilepsy, Parkinson's or Alzheimer's disease

          -  Physical health deficiency

          -  Mental retardation

          -  Neurological or psychiatric disease incompatible with the testing procedure

          -  Schooling in a foreign language

          -  Foreign language spoken at home with both parents

          -  Invalid social security

          -  For the normal hearing subjects, no known hearing deficits
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hung Thai-Van, Professor</last_name>
    <phone>4 72 11 05 03</phone>
    <phone_ext>+33</phone_ext>
    <email>hung.thai-van@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Evelyne Veuillet</last_name>
    <email>evelyne.veuillet@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hung Thai-Van, Professor</last_name>
      <phone>4 72 11 05 03</phone>
      <phone_ext>+33</phone_ext>
      <email>hung.thai-van@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Evelyne Veuillet</last_name>
      <email>evelyne.veuillet@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Eric Truy, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <lastchanged_date>October 8, 2015</lastchanged_date>
  <firstreceived_date>October 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cochlear implant</keyword>
  <keyword>deafness</keyword>
  <keyword>audiometry</keyword>
  <keyword>speech perception</keyword>
  <keyword>severe to profound deafness restored with cochlear implantation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Deafness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
